Serum levels of interleukin-6 and tumor necrosis factor-alpha in exacerbation and remission phase of schizophrenia (original) (raw)

A differential role for interleukin-6 and tumor necrosis factor-α in schizophrenia?

Jean Naudin

Schizophrenia Research, 1997

View PDFchevron_right

Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness

Kuldeep Chengappa

Psychiatry Research, 1994

View PDFchevron_right

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6

Michael Maes

Schizophrenia Research, 1998

View PDFchevron_right

Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment

Palmiero Monteleone

Psychiatry Research, 1997

View PDFchevron_right

Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients

siagian mjulius

View PDFchevron_right

Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology

Dong Zhou

Schizophrenia Research, 2002

View PDFchevron_right

Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia

Sinead O'Brien

Psychiatry research, 2008

View PDFchevron_right

Comparison of Serum Levels of Tumor Necrosis Factor Alpha (TNF-α) in Batak Male Schizophrenic Patients Versus Healthy Controls

SSR Institute of International Journal of Life Sciences

View PDFchevron_right

interleukin-6 in Schizophrenia-is There a Therapeutic Relevance

Milica M . Borovcanin

Front. Psychiatry, 2017

View PDFchevron_right

Interleukin2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

Michael Maes

Journal of Psychiatric Research, 1995

View PDFchevron_right

TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia

Brian Miller

Schizophrenia research, 2018

View PDFchevron_right

Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?

Celso Iglesias

Revista de psiquiatria y salud mental, 2018

View PDFchevron_right

Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder

Dennis Liu

Journal of Neuroinflammation, 2017

View PDFchevron_right

Plasma cytokines in minimally treated schizophrenia

Dania A Jose

Schizophrenia research, 2018

View PDFchevron_right

Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects

Brian Miller

Biological Psychiatry, 2011

View PDFchevron_right

Regulation of interleukin-6 and leptin in schizophrenia patients: a preliminary analysis

Jimmy Lee

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2014

View PDFchevron_right

The relationship between psychopathology and cognitive functions with cytokines in clinically stable patients with schizophrenia

Mesut yıldız

Psychiatry and Clinical Psychopharmacology

View PDFchevron_right

Serum TNF-α, IL-10 and IL-2 in Schizophrenic Patients before and after Treatment with Risperidone and Clozapine

Mehrdad Taghipour

View PDFchevron_right

Serum IL-1β, sIL-2R, IL-6, IL-8 and TNF-α in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment

Hasan Herken

Mediators of Inflammation, 2001

View PDFchevron_right

[ARTICLE] The role of tumor necrosis factor alpha and soluble tumor necrosis factor alpha receptors in the symptomatology of schizophrenia

Sedat Batmaz, haldun soygur, Sibel Kocbiyik

View PDFchevron_right

THE ROLE OF TUMOR NECROSIS FACTOR ALPHA AND SOLUBLE TUMOR NECROSIS FACTOR ALPHA RECEPTORS IN THE SYMPTOMATOLOGY OF SCHIZOPHRENIA

levent turhan

View PDFchevron_right

Cytokine profiles in drug-naive schizophrenic patients

Mario Clerici

Schizophrenia Research, 2001

View PDFchevron_right

Serum Interleukin 1 and Interleukin 2 Levels in Patients with Schizophrenia

Mesut Cetin

Journal of International Medical Research, 2002

View PDFchevron_right

Serum Interleukin 1α and Interleukin 2 Levels in Patients with Schizophrenia

Mesut Cetin

Journal of International Medical Research, 2002

View PDFchevron_right

Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship

Carlos Spuch, Roberto C Agís-Balboa

View PDFchevron_right

Association of plasma IL-6 and soluble IL-6 receptor levels with the Asp358Ala polymorphism of the IL-6 receptor gene in schizophrenic patients

Kunimasa Arima

Journal of Psychiatric Research, 2011

View PDFchevron_right

Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review

edouard kouassi, Emmanuel Stip

Biological Psychiatry, 2008

View PDFchevron_right

Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance

Flávio Kapczinski

Revista Brasileira de Psiquiatria, 2011

View PDFchevron_right